Partner Nate Lacktman was quoted in a Miami Today article, “Equal Insurance Coverage for Telehealth Remains Elusive,” about Senate Bill 280, Florida’s telehealth bill.
Lacktman said the bill is “very disappointing” as it does not include recommendations from the Telehealth Advisory Council’s report on the state of telehealth in Florida, one of which being to allow insurance coverage for telehealth services. He explained that since Florida residents rely heavily on their insurance plans, this would keep Florida behind other states in offering cutting-edge health care services. Lacktman noted that the bill contains a few positives, including its definition of telehealth and the ability to prescribe controlled substances and conduct examinations through telehealth services.
Print only.
Lacktman said the bill is “very disappointing” as it does not include recommendations from the Telehealth Advisory Council’s report on the state of telehealth in Florida, one of which being to allow insurance coverage for telehealth services. He explained that since Florida residents rely heavily on their insurance plans, this would keep Florida behind other states in offering cutting-edge health care services. Lacktman noted that the bill contains a few positives, including its definition of telehealth and the ability to prescribe controlled substances and conduct examinations through telehealth services.
Print only.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”